{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-055788","form_type":"8-K","ticker":"OGN","cik":"0001821825","company_name":"Organon & Co.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.872339+00:00","generated_at":"2026-06-15T22:51:57.688158+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Organon Q1 revenue $1.54B, net income $177M (-49%), adjusted EPS $1.08","bullets":["Revenue of $1,538M, down 2% as-reported but up 3% ex-FX vs Q1 2022; all three franchises grew on constant currency basis.","GAAP diluted EPS $0.69 (down 49% YoY); non-GAAP adjusted diluted EPS $1.08 (down 35% YoY); includes $0.03 negative impact from IPR&D costs.","Adjusted EBITDA $518M (down 20% YoY); margin 33.7% vs 41.3% in Q1 2022.","Board declared $0.28 quarterly dividend; voluntary $250M debt repayment on term loan.","Full year 2023 financial guidance ranges affirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-055788","json":"https://secwatch.observer/filing/0001104659-23-055788.json","markdown":"https://secwatch.observer/filing/0001104659-23-055788.md","text":"https://secwatch.observer/filing/0001104659-23-055788.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821825/000110465923055788/0001104659-23-055788-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821825/000110465923055788/tm2314412d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T22:51:57.688158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}